Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Melanoma: assessment and management

NICE guideline
Reference number: NG14
Published: 29 July 2015
Last updated: 27 July 2022

History

Equality and health inequalities assessment

Equality impact assessment (PDF 240 KB)

Published:

27 July 2022

Consultation comments published

Consultation comments and responses (PDF 1.56 MB)

Published:

27 July 2022

Draft guidance consultation

Draft guidance consultation
Committee member list (PDF 134 KB)

Published:

28 January 2022
Committee member list DOI (PDF 575 KB)

Published:

28 January 2022
Equality impact assessment (PDF 221 KB)

Published:

28 January 2022
Evidence review A (PDF 1.71 MB)

Published:

28 January 2022
Evidence review B (PDF 5.58 MB)

Published:

28 January 2022
Evidence review C (PDF 3.04 MB)

Published:

28 January 2022
Evidence review D (PDF 1.25 MB)

Published:

28 January 2022
Evidence review E (PDF 602 KB)

Published:

28 January 2022
Evidence review F (PDF 7.53 MB)

Published:

28 January 2022
Evidence review G (PDF 10.7 MB)

Published:

28 January 2022
Economic report 1.1 (PDF 1.33 MB)

Published:

28 January 2022
Economic report 5.1 (PDF 2.13 MB)

Published:

28 January 2022
Economic report 6.2 (PDF 2.23 MB)

Published:

28 January 2022
Comments form (MSWord 40 KB)

Published:

28 January 2022
Draft guideline (PDF 512 KB)

Published:

28 January 2022
Supporting documentation non-surgical treatment options for in-transit metastases (PDF 169 KB)

Published:

28 January 2022

Pre-consultation documents released

Economic plan (PDF 154 KB)

Published:

19 November 2021
Search strategies (PDF 387 KB)

Published:

19 November 2021
Review questions (PDF 151 KB)

Published:

19 November 2021

Declaration of interests

Register of interests (PDF 575 KB)

Published:

28 January 2022

Committee list updated

Committee member list (PDF 131 KB)

Published:

26 January 2021

Committee meetings

Committee meeting
Minutes 1 (PDF 202 KB)

Published:

27 July 2020
Minutes 2 (PDF 206 KB)

Published:

07 September 2020
Minutes 3 (PDF 183 KB)

Published:

08 September 2020
Minutes 4 (PDF 210 KB)

Published:

16 October 2020
Minutes 5 (PDF 218 KB)

Published:

23 November 2020
Minutes 6 (PDF 216 KB)

Published:

26 January 2021
Minutes 7 (PDF 219 KB)

Published:

27 January 2021
Minutes 8 (PDF 216 KB)

Published:

09 March 2021
Minutes 9 (PDF 252 KB)

Published:

21 April 2021
Minutes 10 (Day 1 of 2) (PDF 220 KB)

Published:

08 June 2021
Minutes 10 (Day 2 of 2) (PDF 219 KB)

Published:

09 June 2021
Minutes 11 (PDF 218 KB)

Published:

19 July 2021
Minutes 12 (PDF 257 KB)

Published:

15 September 2021
Minutes 13 (PDF 229 KB)

Published:

29 November 2021
Minutes 14 (PDF 222 KB)

Published:

25 July 2022

Scope published

Equality impact assessment 2 (PDF 156 KB)

Published:

02 June 2020
Consultation comments and responses (PDF 429 KB)

Published:

02 June 2020
Final scope - June 2020 (PDF 194 KB)

Published:

02 June 2020
Final scope revised - December 2020 (PDF 309 KB)

Published:

20 December 2020
Final scope Revised Jan 2022 (PDF 259 KB)

Published:

04 January 2022

Draft scope consultation

Draft scope consultation
Draft scope (PDF 401 KB)

Published:

14 January 2020
Equality impact assessment 1 (PDF 125 KB)

Published:

14 January 2020
Comments form (MSWord 35 KB)

Published:

14 January 2020

Stakeholder list updated

Stakeholder list (PDF 134 KB)

Published:

27 July 2022

Scoping workshop: Manchester

Workshop notes (PDF 224 KB)

Published:

14 January 2020

Original development on 01 July 2015

Stakeholder list updated
Stakeholder list (PDF 110 KB)

Published:

30 May 2019
Surveillance consultation
Surveillance consultation
Comments form (MSWord 29 KB)

Published:

19 March 2019
Surveillance review proposal (PDF 1.02 MB)

Published:

19 March 2019
Stakeholder list (PDF 109 KB)

Published:

19 March 2019
Committee meeting
Minutes 12 (PDF 77 KB)

Published:

30 March 2016
Minutes 13 (PDF 74 KB)

Published:

30 March 2016
Health economic plan
Health economic plan
Search strategies (PDF 681 KB)

Published:

19 December 2014
Health economic plan (PDF 115 KB)

Published:

19 December 2014
Review questions (PDF 70 KB)

Published:

19 December 2014
Stakeholder list
Stakeholder list (PDF 83 KB)

Published:

26 January 2015
Guideline development and consultation
Guideline development and consultation
Guideline consultation comments (PDF 919 KB)

Published:

29 July 2015
Equality impact assessment - recommendations (PDF 195 KB)

Published:

29 July 2015
Guideline consultation information
Draft NICE guideline (PDF 559 KB)

Published:

30 January 2015
Draft guideline (PDF 3.29 MB)

Published:

30 January 2015
Appendices (PDF 3.53 MB)

Published:

30 January 2015
Evidence review (PDF 8.93 MB)

Published:

30 January 2015
Economic model confidentiality form (PDF 66 KB)

Published:

03 February 2015
GDG minutes
GDG 11 minutes 1-2 October 2014 (PDF 76 KB)

Published:

01 December 2014
GDG 10 Minutes 15-16 September 2014 (PDF 76 KB)

Published:

21 October 2014
GDG 9 minutes 25 July 2014 (PDF 130 KB)

Published:

21 October 2014
GDG 8 minutes - 10 and 11 June 2014 (PDF 150 KB)

Published:

04 September 2014
GDG 7 minutes - 30 April 2014 (PDF 88 KB)

Published:

04 September 2014
GDG 6 minutes - 6 March 2014 (PDF 88 KB)

Published:

28 May 2014
GDG 5 minutes - 20 & 21 January 2014 (PDF 88 KB)

Published:

18 March 2014
GDG 4 minutes - 15 November 2013 (PDF 98 KB)

Published:

11 February 2014
GDG 3 minutes - 13 September 2013 (PDF 90 KB)

Published:

09 January 2014
GDG 2 minutes - 23 July 2013 (PDF 77 KB)

Published:

09 January 2014
GDG 1 minutes - 21-22 May 2013 (PDF 141 KB)

Published:

30 August 2013
GDG members list (PDF 50 KB)

Published:

06 February 2015
Remit
Remit (PDF 10 KB)

Published:

18 October 2012
Scoping workshop, consultation and final scope
Scoping workshop, consultation and final scope
Scope (PDF 191 KB)

Published:

01 July 2015
Scope consultation comments (PDF 331 KB)

Published:

16 May 2013
Equality impact assessment form - scoping (PDF 221 KB)

Published:

16 May 2013
Scope consultation information
Draft scope (PDF 128 KB)

Published:

28 December 2012
Workshop notes (PDF 144 KB)

Published:

28 December 2012